Clinical Trials Browser

Phase 2 × Sarcoma × Erlotinib Hydrochloride × Clear all

NCT00068367 2017-11-06

S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor

Phase 2 Completed

24 enrolled 7 charts

Sarcoma, Neurofibrosarcoma